申请人:Dainippon Sumitomo Pharma Co., Ltd.
公开号:EP2119702A1
公开(公告)日:2009-11-18
The present invention relates to a compound of the formula (I) being useful as a renin inhibitor, or a pharmaceutically acceptable salt thereof.
wherein R1a is a hydrogen atom, an optionally substituted C1-6 alkyl, etc.; R1b is an optionally substituted C1-6 alkoxy, etc.; R1c is a hydrogen atom, an optionally substituted C1-6 alkoxy, etc.; R2 is a hydrogen atom, an optionally substituted C1-6 alkyl, etc.; R3a, R3b, R3c and R3d are independently the same or different, and each is a group of the formula: -A-B (in which A is a single bond, -(CH2)sO-, - (CH2)sN(R4)CO-, etc., B is a hydrogen atom, an optionally substituted C1-6 alkyl, etc.), etc.; R4 is a hydrogen atom, an optionally substituted C1-6 alkyl, etc.; s is 0, etc.; and n is 1, etc.
本发明涉及一种可用作肾素抑制剂的式 (I) 化合物或其药学上可接受的盐。
其中 R1a 是氢原子、任选取代的 C1-6 烷基等;R1b 是任选取代的 C1-6 烷氧基等;R1c 是氢原子、任选取代的 C1-6 烷氧基等;R2 是氢原子、任选取代的 C1-6 烷基等;R3a、R3b、R3c 和 R3d 独立地相同或不同,且各自是式中的基团:-A-B(其中 A 是单键、-(CH2)sO-、-(CH2)sN(R4)CO- 等,B 是氢原子、任选取代的 C1-6 烷基等)等;R4 是氢原子、任选取代的 C1-6 烷基等;s 是 0 等;n 是 1 等。